PARTNERING

ALLIANCES AND PARTNERING OPPORTUNITIES

PCI Biotech is an oncology-focused company developing innovative products for cancer treatment. The products are based on PCI Biotech’s patented technology, photochemical internalisation ("PCI"). The PCI technology can enhance the effect of anticancer drugs by targeted, light-directed drug delivery into cancer cells, and can also be used as a platform that may both potentiate the effect of vaccines and enable macromolecules such as RNA therapeutics to reach intracellular targets. Our objective is to deliver value to cancer patients through the development of products within two major anticancer treatment paradigms:

fimaVACC - Novel mechanism of action of the PCI technology to be used as a CTL induction technology for therapeutic and prophylactic vaccination with potential value creation in both cancer and infectious diseases. PCI Biotech’s fimaVACC programme aims to enhance immunotherapy in cancer, by triggered endosomal release of antigens or nucleic acids encoding antigens, or immunostimulatory factors. Enhancement of relevant immune responses with protein- and peptide-based vaccines were successfully demonstrated in humans through a Phase I study in healthy subjects.

fimaNAC - Novel delivery technology for pharmaceutical and biotechnology companies looking to overcome the challenge of introducing therapeutics into cells. The technology utilises endosomal release to provide intracellular delivery of nucleic acids, such as mRNA and siRNA therapeutics, thereby addressing one of the major bottlenecks facing this emerging and promising field.

COLLABORATIONS
To fully exploit the potential of our two major PCI applications, we are looking for partnerships with renowned pharmaceutical and biotech companies. Together, we will unlock the potential of your drug candidates. We continue to commit to partners with synergistic ideas to develop innovative drug candidates. Partners should share our vision to develop and commercialize the next generation of therapeutics.
Where to meet us: List of all events where we are planning to attend during current half year, with a link to the event:
BIO-Europe Spring, Barcelona, Spain, 18-20 March 2024
How to contact us: Partnering(at)pcibiotech.no